Celon Pharma S.A. (CLNPHARMA) aksje
CLN.WA
Forsinket 0 minzł20.55-0.10 (-0.48%)
Laster graf...
CLNPHARMA
Market Cap
$1,106,750,976
Åpning20.60
Høy20.60
Lav20.35
Volum3.11k
P/E10.07
Markedsverdi1.11B
52-ukers høy25.30
52-ukers lav18.50
Gj.sn. volum9.03k
UtbytteN/A
Beta0.72
EPS2.04
Om Celon Pharma S.A. (CLNPHARMA) aksje
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.
Selskapsinformasjon
Børs: Warsaw (WSE)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
Ogrodowa 2A
05-092 Lomianki, Poland
05-092 Lomianki, Poland
Telefon: + 48 227 51 59 33
Nettside: https://www.celonpharma.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:3.40 - hold
Laveste kursmål
16.00
↓ 22.1%
Gjennomsnittlig kursmål
20.44
↓ 0.5%
Median kursmål
21.00
↑ 2.2%
Høyeste kursmål
25.50
↑ 24.1%